Created projects

Live projects

No projects found.

Draft projects

No projects found.

Pending Projects

No projects found.

Membership Projects

No projects found.

Suspended Projects

No projects found.

Expired Projects

    No projects found.

view all

You are logged in as Log out

Pregnabit - CTG telesystem: Unique technology procedures to improve prenatal care

by Nico Konrad

Nestmedics flagship Product Pregnabit is a mobile medical device that combines a telemedical cardiotocography unit (teleCTG) with expert remote analysis of CTG readouts by qualified medical personnel
Warsaw, MZ Poland Maternal Health Equity Raise 2021 Vision challenge

All Team Company Patients Physicians Hospital Partners Mission Innovation Details Investor Info Due Diligence Docs Supporters Comments Updates

About our project

The problem we solve: Doctors/clinics: -Shortage of fundamental services -Lack of time and attention -Low reliability of analysis due to episodic, reactive and unconnected treatment Expecting Mothers: -Loss of time away from work and childcare -Personal anxiety and stress -Lack of continuous support -Fear of frequent hospital visits due to infection risks (aggravated by COVID-19)

About our solution: Product Benefits: -Small and easy to handle -Reviewing of data history and real-time insight in current data stream -Secure data cloud storage -High reliability of information/ measurement -Easy „Plug and play” (no setup needed) -Early detection of potential complications Patient Benefits: - Safety & Certainty - Stress minimization & Comfort - Enable rapid decision making -Reduction of pregnancy related absence from work Doctors and Midwives Benefits: -Additional income -Full and remote patient history access -Reduction of queues and increased doctor availability -USP to other obstetrics practices Overall: 1. More safety & convenience 2. Less cost & hassle 3. Better clinical outcome

Progress to date:

Nestmedic is in the last stages of finalizing their next Product Pregnabit®Pro and start a global scalable sales campaign in the USA after FDA approval.

36 customers and 115 devices currently operating on the market with over 12 000 tests in Poland and in Europe.

Pregnabit has become a very valuable solution during the global COVID-19 pandemic: Over 70 new contracts in B2C model in Q2/2020 and an increase of 257% compared to Q1.

Hospitals, private healthcare, insurers and midwives appreciate Pregnabit:  limits visits and hospitalizations of pregnant women.

Various Venture Funds and Private Equity companies believe in Nestmedic’s business model and have invested EUR 3 million.

Additionally, a grant of EUR 850k from the European Union has been received to boost research and development.

Funding needed for acceleration of geographical expansion with access to over 6 million potential end-users* in the EU and especially in the US after FDA approval.

About Our Team

Creator: Nico Konrad

Location: Berry Islands

Education: University of Mannheim - M.Sc.

Bio: I am convinced of PhD management with many years of experience in -managing production, service and technology companies in the medical industry -35 years experience in founding/ running/ managing IT companies & creating IT solutions. -managing and developing telemedicine products in companies such as InfoScan,Cardio.link and EFM -10 years of experience in quality and regulations for medical devices at BD, PRO-PHARM and USP.

Title: Investor Relations Manager

About Team Members

Jacek Gnich
CEO, BA
Biography: Chairman of the Management Board w Nestmedic S.A. A financier by education. Many years of experience in managing production, service and technology companies in the medical industry such as IMPAQ, Infoscan and Impera Capital. He specializes in strategic, financial and operational management.
Title: CEO
Advanced Degree(s): BA
LinkedIn: https://www.linkedin.com/in/gnich-jacek-21764417/

About Our Company

Nestmedic S.A.

Location: ul. Gwia?dzista 15a lok. 410
Warsaw, MZ 01656
PL

Founded: 2014

Website: https://nestmedic.com/

Facebook: https://www.facebook.com/PregnabitPolska

Other link: https://www.pregnabit.com/

Product Stage: In the Market

Employees: 5-10

How We Help Patients

For parents: Why is it worth using the Pregnabit CTG telemedicine system? It is possible to safely carry out a CTG monitoring on your own, almost anywhere – at home, on vacation, during the weekend. Should any threat be recognized, a prompt and decisive actions are taken by the medical telemonitoring centre. User-friendliness of a professional CTG, which is an intuitive and small machine. Ability to access online current and historical CTG tests, both by the patient and the doctor or midwife. Reducing to minimum the need of doing CTG examinations in medical centers resulting in reducing travelling and queuing times. Convenience, comfort, intimacy and the opportunity to participate in the tests of our loved ones.

How We Help Physicians

For medical staff: Why is it worth using the Pregnabit CTG telemedicine system? Possibility of continuous remote monitoring of patients in the third trimester of pregnancy, Access to a qualified and experienced team of experts at the Medical Telemonitoring Center On-line access to current and historical patient's CTG tests and results, Comfortable diagnosis of CTG for patients, also in home conditions, Opportunity to stand out from the competitive offices / clinics by offering an innovative service/ USP to other obstetrics practices Additional income Reduction of queues and increased doctor availability

How We Help Hospitals

For medical staff: Why is it worth using the Pregnabit CTG telemedicine system? Possibility of continuous remote monitoring of patients in the third trimester of pregnancy, Access to a qualified and experienced team of experts at the Medical Telemonitoring Center On-line access to current and historical patient's CTG tests and results, Comfortable diagnosis of CTG for patients, also in home conditions, Opportunity to stand out from the competitive offices / clinics by offering an innovative service/ USP to other obstetrics practices Additional income Reduction of queues and increased doctor availability

How We Help Partners

For medical staff: Why is it worth using the Pregnabit CTG telemedicine system? Possibility of continuous remote monitoring of patients in the third trimester of pregnancy, Access to a qualified and experienced team of experts at the Medical Telemonitoring Center On-line access to current and historical patient's CTG tests and results, Comfortable diagnosis of CTG for patients, also in home conditions, Opportunity to stand out from the competitive offices / clinics by offering an innovative service/ USP to other obstetrics practices Additional income Reduction of queues and increased doctor availability

Innovation Details

Intellectual Property Summary

Nestmedic‘s Patent application no. P.400597 "Method for monitoring fetal health and device for monitoring fetal health“

Integration between the device and a properly functioning teleCTG Monitoring Centre

Distribution of teleCTG device and CTG readout analysis services in multiple countries

Clinical Information

Pregnabit has already achieved to be registered as a certified medical device (CE certified)

 

Regulatory Status

FDA approval expected soon in order to start USA expansion in 1stQ 2021

How we will use the funds raised

Investments needed for 

-Acceleration of geographical expansion with access to over 6 million potential end-users in the EU and especially in the US after FDA approval

-FDA approval process plus initial marketing in the US

-Pregnabit Pro development of hardware and software with the following features

•Access to the patient’s account by several subjects (clinics, doctors)

•Several business structures on one central Telemedical Platform

•Advanced Pulse FHR & TOCO probes of (Philips comparable) quality

•Audio processing module offering exciting sound experience for the mother

•Adjustment to GSM standards for different markets and countries

•Cybersecurity level demanded by western medical institutions

•Computing power easily scalable to eventually growing data traffic

•Documents and effects facilitating the FDA certification process

•Own a computer module for the examination data analysis included

•Integrated tools for devices’ logistics, remote technical supervision etc.

•Graphically attractive and social-media-ready patient’s module

Thank You

Our goal is to be with expecting mothers, giving them the chance to monitor the health of their child anywhere and any time.

Investor Info

Market Size

"70% prefer using a digital solution to monitor their health metrics at home.“- McKinsey & Company

"Personalized Technology will upend the Doctor Patient Relationship“ - Harvard Business Review

"80 percent of the things doctors do today will be done by machines” - Vinod Khosla: billionaire investor

"From USD 111.4 billion in 2019, the global digital health market is predicted to grow to USD 510.4 billion by 2025, registering a CAGR of 29.0% during the forecast period (2020–2025)” - Zion Research, July 2018

"The cumulative costs of childbirth is estimated at well over USD 50 billion annually in the US alone. - The New York Times, June 2013

"540,000 babies are annually born preterm in the US alone with a total annual burden of more than USD 26 billion. - The National Academy of Medicine

 

 

Projected 3 Year Growth

Revenue Model

By providing the medical device and access to the analysis platform to doctors, clinics/hospitals, distributors (B2B) or directly to pregnant women (B2C) for a compensation of 

- €3999 up-front + €49-99 monthly or

-24 monthly installments payment of €199  + €99 monthly

-Rental only for patients €99 / 2 weeks

Competitors

Pregnabit outperforms the competition in tech and user-friendliness

Due Diligence Docs

Please note that access to the company's confidential materials is limited. Click this button to request access from the Company and its representatives.


Supporters

Comments

  • image
    Joanna Greń posted on 10th November, 2020

    Great project! Very important for the mother-to-be, especially during a pandemic

  • image
    ANNA SZOPA posted on 10th November, 2020

    An amazing medical device dedicated to pregnant women! During the pandemic, telemedicine is very important as it helps patients stay at home and still remain under medical supervision.

Login to post your comment!
Click here to Login

Updates

    No updates found .

48
Medstartr
Index Score

48

Interest
Score

0

Adoption
Score
  • 26 Days left

zÅ‚ 50 pledged of zÅ‚ 1,000,000 goal


Nico Konrad
Investor Relations Manager
University of Mannheim - M.Sc.

Proflle
Contact Me


Rewards All contributions are tax-deductible.